● Recruiting

A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer

Condition: Neoplasms, Prostate · Sponsor: GlaxoSmithKline

PhasePhase 1/Phase 2

Planned participants85

Who can joinMale, 18 Years to no upper limit

Healthy volunteersNo

About this study

The goal of the study is to evaluate how safe and how well the body handles GSK5458514 when administered in participants with prostate cancer. The study will be conducted in two parts - Part 1 (dose escalation phase) and Part 2 (dose expansion phase).

This description comes directly from the study's public registry record.

Talk to the study team

US GSK Clinical Trials Call Center · 877-379-3718 · GSKClinicalSupportHD@gsk.com

EU GSK Clinical Trials Call Center · +44 (0) 20 89904466 · GSKClinicalSupportHD@gsk.com

Always discuss trial participation with your own doctor first.

Locations (19)

GSK Investigational Site	Phoenix, Arizona, United States	Recruiting
GSK Investigational Site	Denver, Colorado, United States	Recruiting
GSK Investigational Site	New Haven, Connecticut, United States	Recruiting
GSK Investigational Site	Rochester, Minnesota, United States	Recruiting
GSK Investigational Site	East Brunswick, New Jersey, United States	Recruiting
GSK Investigational Site	Nashville, Tennessee, United States	Recruiting
GSK Investigational Site	Montreal, Quebec, Canada	Recruiting
GSK Investigational Site	Montreal, Quebec, Canada	Recruiting
GSK Investigational Site	Lyon, France	Recruiting
GSK Investigational Site	Villejuif, France	Recruiting
GSK Investigational Site	Kanagawa, Japan	Recruiting
GSK Investigational Site	Tokyo, Japan	Recruiting

+ 7 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06990880